Page last updated: 2024-08-18

quinuclidines and Cystadenocarcinoma, Serous

quinuclidines has been researched along with Cystadenocarcinoma, Serous in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alfredsson, J; Bajalica-Lagercrantz, S; Fransson, Å; Glaessgen, D; Mohell, N; Wiman, KG	1

Other Studies

1 other study(ies) available for quinuclidines and Cystadenocarcinoma, Serous

Article	Year
Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer. Journal of ovarian research, 2016, May-14, Volume: 9, Issue:1 Topics: Antineoplastic Agents; Cell Survival; Cisplatin; Cystadenocarcinoma, Serous; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Inhibitory Concentration 50; Mutation; Neoplasm Grading; Neoplasm Staging; Ovarian Neoplasms; Quinuclidines; Tumor Suppressor Protein p53	2016

Article

Year

Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer.

Journal of ovarian research, 2016, May-14, Volume: 9, Issue:1

Topics: Antineoplastic Agents; Cell Survival; Cisplatin; Cystadenocarcinoma, Serous; DNA Damage; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Inhibitory Concentration 50; Mutation; Neoplasm Grading; Neoplasm Staging; Ovarian Neoplasms; Quinuclidines; Tumor Suppressor Protein p53

2016